ArticleTranslational cancer research2026
Sequential HER2-targeted antibody-drug conjugate therapy for acquired resistance in a 55-year-old male kidney transplant recipient with metastatic urothelial carcinoma: a case report.
Tianying Li et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.